Chemo Mouthpiece, LLC develops the Chemo Mouthpiece™, a cryotherapy device designed to cool the oral mucosa and reduce the incidence and severity of chemotherapy-induced oral mucositis in adult patients. This device utilizes a dual-chamber system with a frozen inner chamber and a saline-filled outer chamber to uniformly lower oral temperature by an average of 31.2 degrees F, outperforming traditional ice chips.
Funding
$15.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chemotherapy-induced oral mucositis (OM) is a common and debilitating side effect, causing pain, difficulty eating, and increased risk of infection. Traditional methods like ice chips provide inconsistent cooling and can be difficult for patients to tolerate, leading to suboptimal prevention of OM.
Solution
Chemo Mouthpiece, LLC offers the Chemo Mouthpiece™, a cryotherapy device designed to reduce the incidence and severity of chemotherapy-induced oral mucositis in adult patients. The device features a dual-chamber system: an inner chamber filled with filtered water that freezes and an outer chamber filled with saline solution that remains liquid. This design ensures uniform cooling of the entire oral cavity, reducing blood flow and limiting the amount of chemotherapy drugs reaching the oral mucosa. The Chemo Mouthpiece™ provides a more efficient and tolerable alternative to ice chips for oral cryotherapy.
Target Audience
The primary target audience includes adult patients undergoing chemotherapy treatment who are at risk of developing oral mucositis.
Features
- Dual-chamber design with frozen inner water chamber and liquid saline outer chamber for consistent cooling.
- Medical-grade silicone construction for patient safety and comfort.
- Uniform cooling of the entire oral cavity, unlike traditional ice chips.
- Reduces oral temperature by an average of 31.2 degrees Fahrenheit.
- 510(k) cleared for marketing in the United States.
- Multiple patents filed in the US and globally.